» Orexigen(R) Therapeutics Announces Completion Of Patient <b>...</b>
(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, announced completion of enrollment in NB-303 and NB-304, the final two…